InfuSystem Holdings, Inc.

NYSE American INFU

InfuSystem Holdings, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 13.36%

InfuSystem Holdings, Inc. EBITDA Margin is 13.36% for the Trailing 12 Months (TTM) ending September 30, 2024, a -0.09% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

InfuSystem Holdings, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 13.38%, a -10.43% change year over year.
InfuSystem Holdings, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 14.93%, a -9.32% change year over year.
InfuSystem Holdings, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 16.47%, a -31.44% change year over year.
InfuSystem Holdings, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 24.02%, a 47.76% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

NYSE American: INFU

InfuSystem Holdings, Inc.

CEO	Mr. Richard A. DiIorio
IPO Date	Dec. 27, 2007
Location	United States
Headquarters	3851 West Hamlin Road
Employees	499
Sector	Health Care
Industries Pharmaceuticals Hospitals & Clinics

Description

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Key trends

Past 5 years